Literature DB >> 25833962

TGF-β signaling in the control of hematopoietic stem cells.

Ulrika Blank1, Stefan Karlsson1.   

Abstract

Blood is a tissue with high cellular turnover, and its production is a tightly orchestrated process that requires constant replenishment. All mature blood cells are generated from hematopoietic stem cells (HSCs), which are the self-renewing units that sustain lifelong hematopoiesis. HSC behavior, such as self-renewal and quiescence, is regulated by a wide array of factors, including external signaling cues present in the bone marrow. The transforming growth factor-β (TGF-β) family of cytokines constitutes a multifunctional signaling circuitry, which regulates pivotal functions related to cell fate and behavior in virtually all tissues of the body. In the hematopoietic system, TGF-β signaling controls a wide spectrum of biological processes, from homeostasis of the immune system to quiescence and self-renewal of HSCs. Here, we review key features and emerging concepts pertaining to TGF-β and downstream signaling pathways in normal HSC biology, featuring aspects of aging, hematologic disease, and how this circuitry may be exploited for clinical purposes in the future.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25833962     DOI: 10.1182/blood-2014-12-618090

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  106 in total

1.  Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis.

Authors:  Catharina Wenk; Anne-Kathrin Garz; Sonja Grath; Christina Huberle; Denis Witham; Marie Weickert; Roberto Malinverni; Julia Niggemeyer; Michèle Kyncl; Judith Hecker; Charlotta Pagel; Christopher B Mulholland; Catharina Müller-Thomas; Heinrich Leonhardt; Florian Bassermann; Robert A J Oostendorp; Klaus H Metzeler; Marcus Buschbeck; Katharina S Götze
Journal:  Blood Adv       Date:  2018-12-11

Review 2.  Transforming growth factor (TGF)-β pathway as a therapeutic target in lower risk myelodysplastic syndromes.

Authors:  Jan Philipp Bewersdorf; Amer M Zeidan
Journal:  Leukemia       Date:  2019-04-08       Impact factor: 11.528

3.  Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia.

Authors:  Alessia Oppezzo; Julie Bourseguin; Emilie Renaud; Patrycja Pawlikowska; Filippo Rosselli
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 4.  Adrenergic Modulation of Hematopoiesis.

Authors:  Georges J M Maestroni
Journal:  J Neuroimmune Pharmacol       Date:  2019-02-14       Impact factor: 4.147

5.  TGF-β: a master regulator of the bone marrow failure puzzle in Fanconi anemia.

Authors:  Paula Río; Juan A Bueren
Journal:  Stem Cell Investig       Date:  2016-11-07

6.  Maintenance of hematopoietic stem cell dormancy: yet another role for the macrophage.

Authors:  Karin Gustafsson; Michael Welsh
Journal:  Stem Cell Investig       Date:  2016-09-19

7.  Aberrant erythropoiesis fuels tumor growth.

Authors:  Kyohei Nakamura; Mark J Smyth
Journal:  Cell Res       Date:  2018-06       Impact factor: 25.617

8.  Cell lineage and communication network inference via optimization for single-cell transcriptomics.

Authors:  Shuxiong Wang; Matthew Karikomi; Adam L MacLean; Qing Nie
Journal:  Nucleic Acids Res       Date:  2019-06-20       Impact factor: 16.971

9.  Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Authors:  Jung Heon Kim; Donna Collins-McMillen; Jason C Buehler; Felicia D Goodrum; Andrew D Yurochko
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

10.  Anticytoproliferative effect of Vitamin C on rat hepatic stellate cell.

Authors:  Min Su; Guo Chao; Minqing Liang; Jianhua Song; Ka Wu
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.